Eradication of Helicobacter pylori

Medical Update for Psychiatrists

Volumn 3, Issue 4, 1998, Pages 99-104

  Worrel, Jodi A ^a,b   Stoner, Steven C ^a,b,c  

^a Northwest Missouri Psychiatric Rehabilitation Center   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; BISMUTH SALICYLATE; CIMETIDINE; CLARITHROMYCIN; FAMOTIDINE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; METRONIDAZOLE; NIZATIDINE; OMEPRAZOLE; PROTON PUMP INHIBITOR; RANITIDINE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE DERIVATIVE;

ANTIBIOTIC THERAPY; ARTICLE; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DUODENUM ULCER; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; ORAL DRUG ADMINISTRATION; STOMACH ULCER;

EID: 0031721283     PISSN: 10827579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1082-7579(98)00012-0     Document Type: Article

References (14)

1. Helicobacter pylori in peptic ulcer disease. JAMA. 272:1994;65-69.
2. Soll AH. Medical treatment of peptic ulcer disease Practice guidelines . JAMA. 275:1996;622-629.
3. Graham DY, Malaty HM, Evans DG, Evans DJ, Klein PD, Adam E. Epidemiology of Helicobacter pylori in an asymptomatic population in the United States Effect of age, race, and socioeconomic status . Gastroenterology. 100:1991;1495-1501.
4. Cutler AF. Testing for Helicobacter pylori in clinical practice. Am J Med. 100:1996;35S-41S.
5. Balaban DH. Medical update: Helicobacter pylori. Medical Update for Psychiatrists. 1:1996;67-70.
6. Jonsson B. Cost-effectiveness of Helicobacter pylori eradication therapy in duodenal ulcer disease. Scand J Gastroenterol. 31:(Suppl 215):1996;90-95.
7. Roggero E, Zucca E, Pinotti G, Pascarella A, Capella C, Savio A, Pedrinis E, Paterlini A, Venco A, Cavalli F. Eradication of Helicobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med. 122:1995;767-769.
8. Olson C, Edmonds A. Primary susceptibility of H. pylori to clarithromycin compared to metronidazole in patients with duodenal ulcers associated with H. pylori infection. Gut. 37:(Suppl. 2):1995;A814.
9. Teicher MH, Altesman RI, Cole JO, Schatzberg AF. Possible nephrotoxic interaction of lithium and metronidazole [letter]. JAMA. 257:1987;3365-3366.
10. Horowitz RS, Dart RC, Gomez HF. Clinical ergotism with lingual ischemia induced by clarithromycin-ergotamine interaction. Arch Intern Med. 156:1996;456-458.
11. Hunt RH. Eradication of Helicobacter pylori infection. Am J Med. 100:(Suppl 5A):1996;42S-51S.
12. Gustavson LE, Kaiser JF, Edmonds AL, Locke CS, DeBartolo ML, Schneck DW. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother. 39:1995;2078-2083.
13. Forbes GM, Glaser ME, Cullen DJ, Warren JR, Christiansen KJ, Marshall BJ, Collins BJ. Duodenal ulcer treated with Helicobacter pylori eradication Seven-year follow-up . Lancet. 343:1994;258-260.
14. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ, Klein PD, Alpert LC, Genta RM. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastrenterology. 102:1992;493-496.